Former Merck executive Peter DeVilbiss jumped into our ongoing discussion of pharma’s big fall. (Update: To be clear, he was responding to comments on this post, which argued that drug companies have done a lot more good than harm — which is true.) He seems to be struggling with two questions I’ve been trying to answer for years: why don’t people like drug companies, and how is it that a once admired and innovative industry has fallen into a rut? And, of course, are the answers to those two questions related to one another?
